Justin Walsh
Stock Analyst at JonesTrading
(4.82)
# 479
Out of 4,698 analysts
399
Total ratings
41.4%
Success rate
26.3%
Average return
Main Sectors:
Stocks Rated by Justin Walsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Maintained: Buy | $50 | $45.77 | +9.24% | 21 | Sep 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $32 | $24.86 | +28.72% | 1 | Aug 25, 2026 | |
| RNXT RenovoRx | Reiterated: Buy | $8 | $2.39 | +234.73% | 6 | Aug 19, 2026 | |
| CLNN Clene | Maintained: Buy | $30 | $3.85 | +679.22% | 15 | Aug 18, 2026 | |
| SER Serina Therapeutics | Reiterated: Buy | $11 | $2.73 | +302.93% | 9 | Aug 18, 2026 | |
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 | $1.62 | +393.83% | 4 | Aug 18, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $18 | $3.13 | +475.08% | 35 | Aug 14, 2026 | |
| ATNM Actinium Pharmaceuticals | Reiterated: Buy | $9 → $3 | $1.03 | +191.26% | 33 | Aug 14, 2026 | |
| LNTH Lantheus Holdings | Reiterated: Hold | n/a | $100.97 | - | 32 | Aug 14, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $74 → $90 | $38.09 | +136.28% | 8 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.00 | +120.00% | 15 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $441 | $351.81 | +25.35% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.67 | - | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.53 | - | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.39 | - | 8 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $35.55 | +23.77% | 19 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $24 | $0.3496 | +6,764.99% | 5 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.49 | +135.57% | 23 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $2.08 | +1,342.31% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.05 | - | 27 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $117.56 | n/a | 7 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.76 | n/a | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.40 | $0.01 | n/a | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.70 | n/a | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $1.59 | n/a | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.35 | n/a | 12 | Jun 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $38.54 | n/a | 2 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.241 | n/a | 15 | May 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.38 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $0.3501 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $58.45 | n/a | 2 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0001 | n/a | 2 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.15 | n/a | 2 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.10 | n/a | 3 | Nov 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $20.56 | n/a | 5 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.0992 | n/a | 1 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $1.57 | n/a | 1 | Feb 17, 2021 |
Rapport Therapeutics
Sep 2, 2026
Maintained: Buy
Price Target: $50
Current: $45.77
Upside: +9.24%
Seaport Therapeutics
Aug 25, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $24.86
Upside: +28.72%
RenovoRx
Aug 19, 2026
Reiterated: Buy
Price Target: $8
Current: $2.39
Upside: +234.73%
Clene
Aug 18, 2026
Maintained: Buy
Price Target: $30
Current: $3.85
Upside: +679.22%
Serina Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $11
Current: $2.73
Upside: +302.93%
NeuroOne Medical Technologies
Aug 18, 2026
Reiterated: Buy
Price Target: $8
Current: $1.62
Upside: +393.83%
Perspective Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $18
Current: $3.13
Upside: +475.08%
Actinium Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $9 → $3
Current: $1.03
Upside: +191.26%
Lantheus Holdings
Aug 14, 2026
Reiterated: Hold
Price Target: n/a
Current: $100.97
Upside: -
Definium Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $74 → $90
Current: $38.09
Upside: +136.28%
Aug 10, 2026
Reiterated: Buy
Price Target: $11
Current: $5.00
Upside: +120.00%
Aug 7, 2026
Reiterated: Buy
Price Target: $441
Current: $351.81
Upside: +25.35%
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $2.67
Upside: -
Jul 31, 2026
Rated: Hold
Price Target: n/a
Current: $3.53
Upside: -
Jul 16, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.39
Upside: -
Jun 26, 2026
Reiterated: Buy
Price Target: $44
Current: $35.55
Upside: +23.77%
May 18, 2026
Reiterated: Buy
Price Target: $60 → $24
Current: $0.3496
Upside: +6,764.99%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $8.49
Upside: +135.57%
Mar 25, 2026
Reiterated: Buy
Price Target: $30
Current: $2.08
Upside: +1,342.31%
Jan 5, 2026
Rated: Hold
Price Target: n/a
Current: $25.05
Upside: -
May 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $117.56
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $2.76
Upside: n/a
Oct 30, 2024
Reiterated: Buy
Price Target: $0.40
Current: $0.01
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $20
Current: $3.70
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $8 → $4
Current: $1.59
Upside: n/a
Jun 6, 2022
Reiterated: Buy
Price Target: $10
Current: $1.35
Upside: n/a
May 19, 2022
Maintained: Buy
Price Target: $16 → $20
Current: $38.54
Upside: n/a
May 19, 2022
Reiterated: Buy
Price Target: $18
Current: $0.241
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $10
Current: $2.38
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $7 → $6
Current: $0.3501
Upside: n/a
Apr 7, 2022
Maintained: Buy
Price Target: $10
Current: $58.45
Upside: n/a
Jan 11, 2022
Upgraded: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $4.15
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $7.10
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: $30
Current: $20.56
Upside: n/a
Sep 2, 2021
Initiated Coverage: Buy
Price Target: $40
Current: $0.0992
Upside: n/a
Feb 17, 2021
Initiated Coverage: Buy
Price Target: $4
Current: $1.57
Upside: n/a